The present study was undertaken to investigate the suitability of a method for the evaluation of the speed of onset of neuromuscular blocking drugs. Previously, such studies have been undertaken by measuring the time from the i.v. injection of the drug to the depression of the muscle twitch or the adequacy of tracheal intubation conditions. However, venousarterial circulation time is variable (Harrison and Junius, 1972) and any evaluation of intubation conditions will always be subjective. The present method, proposed originally by Holst-Larsen (1976) , eliminates inaccuracies as a result of the site and speed of injection and the venous-arterial circulation time. The neuromuscular blockers studied were pancuronium, tubocurarine, alcuronium, fn7jHininm and suxamethonium administered in doses used commonly for tracheal intubation.
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PATIENTS AND METHODS
Fifty female patients were included in an open comparative study. Their ages varied between 28 and 50 yr and their weights from 49 to 75 kg. They were divided into five groups, one for each drug. The mean age and mean weight in each group and the mean drug doses are shown in twitch responses were obtained with the stimulator setting at step 6 or 8, after which the setting was increased to 10 to make sure that the stimulus was supramaximal. Muscle twitches (movement of a pneumatic bulb held in the right hand) were recorded on a Mingograph recorder (Elema-Schmander EMT34 transducer). Paper speed was 2.5 mm s-1 and the ulnar nerve was stimulated at 1 Hz. One minute after the end of the rapid injection of the neuromuscular blocker in the left arm, the tourniquet on the right arm was released suddenly.
Twitches were recorded until the block was complete and at 90% decrease in twitch height the time was noted and endotracheal intubation performed immediately.
RESULTS
Following the sudden release of the cuff pressure (time noted) single twitches continued for a period without alteration in twitch height. This was followed by a clearly defined change showing a gradual decrease in twitch height ( fig. 1 ). The time from the release of the cuff pressure until the first change in twitch height was called the A-M latent onset time (line L in fig. 1 ). The period from the first evidence of any decrease in twitch height until 90% depression of twitch height was called the A-M manifest onset time. The A-M latent onset time plus the A-M manifest onset time equals the A-M total onset time (table II) . It can be seen that there were significant differences between the drugs studied with regard to A-M latent onset times and A-M manifest onset times although it will be observed that, whereas pancuronium had a longer A-M latent onset time than tubocurarine, it had a shorter A-M manifest onset time (table II) . The opposite was true for tubocurarine which had a comparatively rapid A-M latent onset time and a slow and variable A-M manifest onset time. Thus, there was no significant difference in the A-M total onset time between these two drugs.
DISCUSSION
Since, in clinical practice, neuromuscular blocking agents are injected i.v., the time from the Lv. injection of the drug to full neuromuscular blockade is of importance. This period is made up, to a large extent, by the circulation time, which involves possible delays in the right heart, the lungs, the left heart and the vessels. Harrison and Junius (1972) showed that vein-to-artery circulation time was more than doubled in patients with circulatory failure. This variable was eliminated in our study by measuring the time from the release of the tourniquet to the various alterations in twitch height. By this method we found an A-M latent onset time unique for each drug, a feature which has not been described previously following the administration Lv. of alcuronium tubocuronium or pancuronium (Harrison, 1972; Hey, 1973; Blackburn and Morgan, 1978) .
One minute was chosen as the most appropriate period of occlusion of the circulation to the one arm after the injection i.v. of the drug; this was considered to be the minimum time necessary to allow even distribution of the injected drug in the circulation (Kalow, 1959) . Thus on release of the tourniquet, "bolus" effects would be avoided.
The i.v. onset time should equal the A-M latent onset time plus the 30 s found as an average vein-toartery circulation time by Harrison and Junius (1972) . Blackburn and Morgan (1978) have determined, in patients with normal circulations, the times from the Lv. administration of a drug until the production of a 25% depression of twitch height with four of the neuromuscular blockers we have used. With these four drugs our A-M latent onset times phis 30 s came within 10% of the i.v. onset times found by Blackburn and Morgan (1978) . This shows that artery-to-muscle latent onset time is a valid indicator of the speed of onset of a neuromuscular blocker.
A-M latent onset time must represent the time for the relaxant to (a) gain access to the receptors; (b) occupy the receptors sufficiently for blockade to occur. So far we can only speculate on the role played by each of these processes. For suxamethonium, however, we must presume that the value (48 s) found for this drug represented access time only, because the drug is principally an agonist acting instantaneously with the receptors. The 4.8 s found in our study is extremely dose to the 4 s onset time found for acetylcholine itself after injection to the brachial artery in humans (Grob, Johns and Harvey, 1956) .
If the artery-to-muscle latent onset time represents mainly access to the receptors by diffusion, certain physicochemical factors should be of importance. No correlation, however, could be found between latent onset time and the square root of the molecular weight, although this last factor is thought to determine speed of diffusion along a concentration gradient. Information on protein binding is available only for suxamethonium, pancuronium and tubocurarine (Cohen, Brewer and Smith, 1967; ) Dal Santo, 1968; Thompson, 1976) . Of these drugs the last two are protein bound and have the longest onset times while the first is free and has the shortest onset time.
Receptor occupancy by non-depolarizing drugs was shown by Waud and Waud (1975) to have a safety margin of 75-90% for the transmission of single twitches. Paton (1961) , in his kinetic theory, proposed that the speed of action of neuromuscular blockers reflected their rate of receptor occupancy. In 1967, however, Waud applied neuromusculai blocking drugs directly to the receptors in animals and found that they acted as if access was the only rate-limiting factor. In a later review (Waud, 1968) , however, he admits that the rate of combination with the receptor provides a satisfactory explanation for the speed of onset of drugs. This explains why the speed of onset is inversely related to potency. This postulate agrees only partly with our results. Pancuronium, the most potent myoneural blocking drug on the market, has the longest A-M latent onset time. Alcuronium, on the other hand, is more potent than tubocurarine but has a shorter A-M latent onset time and does not fit into the postulate.
In 1973 Feldman showed that depolarizers, such as suxamethonium, lost their effect on the human hand muscles in 1-2 min compared with 15-20 min for the non-depolarizers. It is possible that the nondepolarizers have a stronger affinity for the receptors which manifests itself as a slow onset and a slow dissociation rate whereas the opposite is the case for depolarizers.
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SUMMAHIO
Se Ilev6 a cabo un estudio del principio del efecto arteriaa-musculo (AM) de cinco agentes bloqueadores neuromusculares en 50 pacientes frminiTin* bajo anestesia endotraqueal ligera. Se obstruy6 la circulaci6n en el brazo derecho mediante un torquinete y se solt6 1 min despuis de la inyeccidn i.v. en el brazo izquierdo de una substancia bloqueadora mioneural. Se registraron los crispamientos espasmodicos musculares en la mano derecha despu6s de estimular al nervio ulnar (1 Hz). Una vez soltado el torquinete, la respuesta a crispamientos unicos siguid sin disminuir en su altura (tiempo de inidaddn latente). Se observ6 la inidaciin de disminuciones progresivas de la altura del crispamiento y se midi6 el tiempo hasta que la altura hubiera bajado en un 90% (tiempo de inidad6n manifie8to). Los tiempos medios de iniciacion latente fueron: pancuronio (31,9 s), tubocurarina (21 s), alcuronio (17,2 s), fazadinio (8,6 s) et suxametonio 4,8 s). El tiempo de inidad6n latente promedio (AM) dinri6 signiflcativamente para cada droga (P< 0,005). Los timepos de inidadin maniflestos (AM) se relacionaban a los tiempos de inidad6n latente (AM), salvo en el caso de la tubocurarina que demostro un descenso mas lento de la altura del crispamiento. El tiempo de iniciaci6n latente (AM) se correlacionaba bien con los valores de los tiempos de inidad6n intravenosos indicados en la folleteria.
